Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.
- DOI
- 10.1016/j.bcp.2026.118177
- Published
- 2026-06-22
- Container
- Biochem Pharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118177,
title = {Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.},
author = {Hershberger KK and Thibodeau J and Su Y and Madagundapalli Ramakrishna SS and Singh V and Sharma A and Edwards H and Ge Y and Yang J.},
year = {2026},
journal = {Biochem Pharmacol},
doi = {10.1016/j.bcp.2026.118177},
url = {https://doi.org/10.1016/j.bcp.2026.118177}
}RIS
TY - JOUR TI - Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms. AU - Hershberger KK AU - Thibodeau J AU - Su Y AU - Madagundapalli Ramakrishna SS AU - Singh V AU - Sharma A AU - Edwards H AU - Ge Y AU - Yang J. PY - 2026 JO - Biochem Pharmacol DO - 10.1016/j.bcp.2026.118177 UR - https://doi.org/10.1016/j.bcp.2026.118177 ER -
APA
KK, H., J, T., Y, S., SS, M. R., V, S., A, S., H, E., Y, G., & J., Y. (2026). Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.. Biochem Pharmacol. https://doi.org/10.1016/j.bcp.2026.118177
Source records
- europe-pmc · retrieved 2026-09-25T20:43:41.273Z